MaxCyte, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 2.19M | $1.54M | 0.00% | Trimmed-7.0% | 2026-03-31 |
| RenTech | quant | 1.99M | $1.40M | 0.00% | Added+153.3% | 2026-03-31 |
| TwoSigma | quant | 608.2K | $427.23K | 0.00% | Added+591.7% | 2026-03-31 |
| DEShaw | quant | 200.5K | $140.85K | 0.00% | Trimmed-69.8% | 2026-03-31 |
| FidelityFMR | fundamental | 190.1K | $133.56K | 0.00% | Added+31.7% | 2026-03-31 |
| TRowePrice | fundamental | 51.5K | $37 | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.09 | — | — |
| 2026-03-24 | -0.08 | -0.06 | +32.08% |
| 2025-11-12 | -0.10 | -0.12 | -20.00% |
| 2025-08-06 | -0.10 | -0.12 | -17.65% |
| 2025-05-07 | -0.10 | -0.10 | +2.44% |
| 2025-03-11 | -0.12 | -0.10 | +18.37% |
| 2024-11-06 | -0.12 | -0.11 | +11.29% |
| 2024-08-06 | -0.13 | -0.09 | +29.69% |
| 2024-05-07 | -0.12 | -0.09 | +27.42% |
| 2024-03-12 | -0.07 | -0.05 | +30.56% |
| 2023-11-08 | -0.10 | -0.11 | -7.84% |
| 2023-08-09 | -0.10 | -0.10 | -4.17% |
| 2023-05-10 | -0.11 | -0.11 | +1.79% |
| 2023-03-15 | -0.07 | -0.05 | +28.57% |
| 2022-11-09 | -0.08 | -0.06 | +28.57% |
| 2022-08-10 | -0.07 | -0.08 | -6.67% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| MXCT | +37.50% | +59.21% | -21.94% | -49.16% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +34.53% | +63.85% | -18.49% | -61.85% |